YIH
USNA icon

Y-Intercept (HK)’s Usana Health Sciences USNA Stock Holding History

Y-Intercept (HK)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
+13,975
New +$263K 0.01% 1468
2023
Q2 		– Sell
-4,443
Closed -$279K – 1742
2023
Q1 		$279K Buy
+4,443
New +$265K 0.03% 813

Other funds holding USNA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Park Capital Management Madison, Wisconsin $170M AUM 83.62% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Y-Intercept (HK)'s USNA Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Usana Health Sciences (USNA) in Q2 2026: 13,975 shares worth $298K. The stake represents 0.01% of the portfolio and ranks #1468 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in USNA as recently as Q1 2023.

Y-Intercept (HK) first reported a position in USNA in Q1 2023 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Y-Intercept (HK) held 13,975 shares of Usana Health Sciences worth $298K as of Q2 2026.
  • Usana Health Sciences was a new Y-Intercept (HK) position in Q2 2026.
  • Usana Health Sciences made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1468 holding.
  • Y-Intercept (HK) first reported a position in Usana Health Sciences in Q1 2023 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.